Topics

Charles River signs binding offer to buy Citoxlab for $510m

07:49 EST 15 Feb 2019 | Compelo Medical Devices

Charles River expects the acquisition to close in the second quarter of this year. Citoxlab specializes in regulated safety assessment services, non-regulated discovery services, and medical device testing,

The post Charles River signs binding offer to buy Citoxlab for $510m appeared first on Compelo Medical Devices.

Original Article: Charles River signs binding offer to buy Citoxlab for $510m

NEXT ARTICLE

More From BioPortfolio on "Charles River signs binding offer to buy Citoxlab for $510m"

Quick Search

Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Medical Devices
The role of medical devices in healthcare is essential.  The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare.  Covering a wide range of products, from simple bandages to the...